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Background: The increase of life expectancy in Indonesia 
causes increasing numbers of dementia, mostly caused by 
Alzheimer's disease (AD). High serum cholesterol level 
has been suggested as a risk factor for AD. The strongest 
evidence linking lipid profile with AD provided by 
previous experimental studies where adding or reducing 
cholesterol altered amyloid precursor protein (APP) and 
amyloid β-protein (Aβ) levels is the basic of this research. 
Objective: To determine whether lipid profile is 
associated with cognitive function deterioration of 
geriatric outpatients at Neurology Clinic Gunungsitoli 
Regional General Hospital. 
Methods: Participants of this cross-sectional study were 
outpatient geriatric patients at Neurology Clinic 
Gunungsitoli Regional General Hospital (n=85; mean age, 
62.46±5.49 years old). The cognitive state was evaluated 
using Montreal Cognitive Assessment Indonesian Version 
(MoCA-INA) and those with MoCA-INA score <24 were 
considered cognitively declined. Concentrations of serum 
lipid profile were measured and correlated with cognitive 
state using Pearson’s correlation. 
Multiple logistic regression analysis was used to 
calculate odds ratios (ORs) for cognitive decline. 
Results: Based on Pearson’s correlation test, high-
density lipoprotein (HDL) level had significant 
strong positive correlation with MoCA-INA score 
(r=0.876;p=0.000) and triglyceride level had 
significant strong negative correlation with MoCA-
INA score (r=-0.726;p=0.000). Relatively to 
cognitive decline, ORs for decreased HDL level 
was 3.19 (95%CI 2.02-4.36) and increased 
triglyceride level was 2.59 (95%CI 1.29-3.91). 
Conclusion: There was a significant relationship 
between decreased HDL-cholesterol level and 
increased triglyceride level with cognitive decline 
in geriatric outpatients. 
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The increase of life expectancy in Indonesia from 
70.1 years in 2010-2015 period to 72.2 years in 
2030-2035 period causes increasing number of 
dementia in Indonesia.1,2 Most of the dementia 
case is caused by Alzheimer's disease.2 Alzheimer's 
disease is a neurodegenerative disease causing a 
progressive decline in cognitive function in the 
form of episodic memory and other cortical 
functions as well as motor impairment in the later 
stages of this disease.3 The Delphi Consensus in 
2015 published 10% increase in the prevalence of 
dementia compared to previous publications in 
2005.3 Another research estimated 35,6 million 
people with dementia in 2010 with a doubling 
every 20 years to 65.7 million in 2030 and 115.4 
million in 2050. In Southeast Asia the number of 
people with dementia is estimated to increase 
from 2.48 million in 2010 to 5.3 million in 2030.4 
Increased total serum cholesterol level has been 
shown to increase the risk of developing 
Alzheimer's dementia.5 An early study on 
cholesterol and dementia reported that the 
apolipoprotein E (apoE) genotype which played a 
role in the formation of amyloid β-protein (Aβ) 
plaque and Alzheimer's dementia depended on 
total cholesterol level, age, and patient sex.6 
Recent studies had also found that serum 
cholesterol level was approximately 10% higher in 
patients with Alzheimer's dementia compared to 
control subjects and this difference was statistically 
significant.7 In a longitudinal study, cholesterol 
level was found to be significantly higher on the 
first measurement of patients with Alzheimer's 
dementia when compared with control subjects, 
but did not differ significantly on the second 
measurement from 11 to 26 years after the first 
measurement.8 An odds ratio analysis using 
different models showed that cholesterol level in 
middle age significantly increased the risk for 
developing Alzheimer's dementia.8 Meanwhile, 
another study reported that total serum 
cholesterol level was significantly higher in mild 
cognitive impairment (MCI) subjects compared to 
controls, but it was also observed that elevated 
serum triglyceride and serum high-density 
lipoprotein (HDL) level were significantly 
associated with the occurrence of MCI.9 In 
contrast, there had also been studies reporting 
that serum low-density lipoprotein (LDL) level did 
not differ significantly in patients with Alzheimer's 
dementia compared to control subjects, but total 
cholesterol level was significantly lower in patients 
with Alzheimer's dementia compared to control 
subjects.10 
There was no national research data on the 
prevalence of dementia in Indonesia. However, in 
line with the increasing population growth of 
elderly in Indonesia, there will also be increasing 
number of dementia cases. Dementia is a 
syndrome of decreased intellectual function 
compared to previous condition which is severe 
enough to interfere social and professional 
activities, which is reflected in dependence of the 
patient's daily life activities, usually changes in 




Because of the high prevalence and level of 
dependence due to dementia, researchers were 
interested in conducting a study on the 
relationship between lipid profile and decreased 
cognitive function of geriatric outpatients at 
neurology clinic of Gunungsitoli Regional General 
Hospital, the only one referral hospital in Nias 
Island. This study is expected to be used as basis 
for determining the prognosis of cognitive decline 
in geriatric patients based on their lipid profile. 
Method  
This analytic observational research was conducted 
at neurology clinic and laboratory of Gunungsitoli 
Regional General Hospital from January to May 
2020 with a cross sectional design. The research 
subjects were determined by consecutive sampling 
from geriatric outpatients of neurology clinic 
Gunungsitoli Regional General Hospital which met 
the inclusion and exclusion criteria until the 
analysis requirements was fulfilled. Research 
subjects who met the inclusion criteria signed a 
written informed consent and underwent history 
taking, lipid profile examination, and cognitive 
function test using MoCA-INA test. This study 
design was approved by the local institutional 
review board, Gunungsitoli Regional General 
Hospital Health Research Ethics Committee 





 based on the letter of research recommendation 
from Badan Penelitian, Pengembangan, dan 
Perencanaan Daerah of Nias Regency number 
050/612/Litbangrenc/Bappeda.  
The inclusion criteria were geriatric outpatients 
(aged≥55 years old) of neurology clinic 
Gunungsitoli Regional General Hospital with frailty 
score≤9 based on the Edmonton Frailty Scale, 
agreed to take part in this research proven by 
signing an informed consent, cooperative, fully 
aware (compos mentis), and were able to read and 
write. While the exclusion criteria were patients 
with functional psychiatric disorders; history of 
using systemic psychotropic drugs and cholesterol-
lowering drugs; history of narcotics, alcohol, 
psychotropic substances, and other additives 
abuse; suspicion of space-occupying lesion 
processes or brain tumors; transient ischemic 
attack (TIA); history of stroke, acute coronary 
syndrome, hypertension, and diabetes mellitus; 
history of education less than 6 years; and verbal 
communication difficulties using Indonesian 
language. 
In this study, the lipid profile was the value 
obtained from laboratory examinations of the 
patient's blood in the form of serum HDL, LDL, 
triglycerides, and total cholesterol level carried out 
on the day the patient visited the neurology clinic 
of Gunungsitoli Regional General Hospital. Blood 
samples were drawn from each patient after 
fasting for 10-12 hours and immediately stored at 
4°C. Serum was obtained on the same day by 
centrifugation of the sample at 3500 rpm for 10 
minutes and stored at -30°C until biochemical 
analysis was performed. Researchers used Roche, 
Sigma, and Accurex reagents and kits in this study. 
The decline in cognitive function in the form of the 
MoCA-INA score was carried out on the day the 
patient visited the neurology clinic of Gunungsitoli 
Regional General Hospital. Patients with MoCA-INA 
score<24 were categorized as having decreased 
cognitive function.3 
Furthermore, data collected from this study had 
been analyzed with multiple logistic regression test 
to determine the odds ratios (ORs) between the 
lipid profile and the decline in cognitive function of 
geriatric patients manifested in the form of MoCA-
INA score. Data collected from this study which 
were normally distributed could also be analyzed 
using Pearson correlation test to determine the 
relationship between lipid profiles and decreased 
cognitive function in geriatric patients manifested 
in the form of MoCA-INA score. Results of Pearson 
correlation test were expressed in terms of 
contingency coefficient (r) measuring the direction 
and strength of the linear relationship between the 
two variables. All data analysis process was 
performed using SPSS Windows 22.0 program. 
 
Result 
The subjects of this study were 85 geriatric 
outpatients in neurology clinic of Gunungsitoli 
Regional General Hospital who met the inclusion 
and exclusion criteria, consisting of 40 men 
(47.06%) and 45 women (52.94%). The mean age 
of the study subjects was 62.46±5.49 years old 
with range of age from 56 to 79 years old. 
Total cholesterol level of the study subjects ranged 
from 141–348 mg/dL with average of 217.85±47.39 
mg/dL. Serum HDL level of the study subjects 
ranged from 32-59 mg/dL with average of 
46.81±6.09 mg/dL. Serum LDL level of the study 
subjects ranged from 52-261 mg/dL with average 
of 136.87±41.33 mg/dL. The serum triglyceride 
level of the study subjects ranged from 80-426 
mg/dL with average of 170.61±62.11 mg / dL. 
Cognitive function was measured using MoCA-INA 
test instrument. On this examination, the results of 
MoCA-INA score range were between 19-30 with 
average of 23.82±2.87 as shown in Figure 1. 
The result of One-Sample Kolmogorov-Smirnov test 
using SPSS 22.0 for Windows showed that all data 
were normally distributed (p>0.05). The correlation 
of lipid profile with MoCA-INA score reflecting the 
cognitive function of the study subjects was 
assessed by performing Pearson correlation test to 
determine the contingency coefficient. The test 
results showed a linear correlation with strong and 
statistically significant correlation strength on the 
examination of HDL cholesterol and triglyceride 
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Figure 1. Results of MoCA-INA Score 
 
Figure 2. Correlation between Lipid Profile and MoCA-INA Score
Furthermore, the lipid profile data and MoCA-INA 
score from this study were also analyzed by 
performing multiple logistic regression tests to 
determine the ORs between lipid profile and 
cognitive decline as shown in Figure 3. The 
statistically significant multiple logistic regression 
test results showed ORs for decreased HDL 
cholesterol level on cognitive function was 3.19 
(95%CI 2.02-4.36) and ORs for increased 
triglyceride level on cognitive function was 2.59 
(95%CI 1.29-3.91). Meanwhile, ORs for increased 
total cholesterol level on cognitive function was 
2.07 (95%CI 1.02-3.11) and ORs for increased LDL 
cholesterol level on cognitive function was 1.37 
(95% CI 0.41- 2.34). However, both the ORs value 
for increased total cholesterol level and increased 





 significant as were their correlation to cognitive 
function. 
In addition, researchers also obtained a correlation 
coefficient (R) of 0.772 and a coefficient of 
determination (R2) of 0.752 with significance of 
p=0.000 from the multiple logistic regression test. 
This result showed that there was a close 
relationship between lipid profile and cognitive 
function, where the percentage effect of lipid 
profile on cognitive decline in this study was 75.2% 
and the remaining 24.8% was influenced by other 
factors, like genetic, race, sex, and nutrition.8,10 
 
Discussion  
This study showed a strong and statistically 
significant relationship between lower HDL level or 
higher triglyceride level and the incidence of 
cognitive impairment in geriatric patients. Total 
cholesterol level and LDL level did not show a 
statistically significant association with cognitive 
impairment in geriatric patients. Research from 
Dimopoulos et al. also mentioned a relationship 
between low HDL cholesterol level and high 
triglyceride level with memory problems and 
depression in elderly patient group. 
Lipids and lipoproteins may have direct effect with 
neurodegenerative diseases. There are some 
mechanisms explaining the association between 
low HDL cholesterol level and cognitive 
impairment. HDL is lipoprotein found in plasma 
and cerebrospinal fluid. HDL contains apoE and 
facilitates the reverse transport of cholesterol, the 
transport of other types of cholesterol from 
various tissues (including the brain) to the liver. 
HDL enters the central nervous system via blood-
brain barrier and involved in the regulation of 
metabolism of Aβ, a major constituent of amyloid 
plaque and its accumulation in the brain.12,13 
Research from Exel et al. also supported a direct 
relationship between HDL and cognitive function 
through atherosclerosis mechanism. It had been 
shown that atherosclerosis was associated with 
clinical and subclinical ischemic processes in brain 
contributing to the development of dementia 
onset. Cerebrovascular changes and pathological 
changes in Alzheimer's disease often coincided in 
dementia case and could act synergistically in 
decreased cognitive function. At the same time low 
serum HDL concentration had been associated 
with an increased risk of stroke and patients 
suffering stroke had a higher risk of developing 
Alzheimer's disease.14,15 
Another mechanism linking low HDL level to 
neuronal degeneration may be related to its role as 
an anti-inflammatory or antioxidant agent. The 
neuroprotective properties of HDL include 
accelerated maturation of synapses, maintenance 
of synaptic plasticity, increased Aβ catabolism, 
increased hippocampal volume, anti-inflammatory 
effects, and antioxidant effects. Oxidative stress 
including lipid peroxidation has been shown to be a 
mediator of the pathological effects of risk factors 
for Alzheimer's disease. Because HDL is a 
lipoprotein that is responsible for the processing of 
cholesterol efflux from brain cells, it is possible that 
HDL deficiency or dysfunction can lead to 
tauopathies or dysgenesis of the synaptic process, 
so that individuals with dyslipidemia may be more 
susceptible to neurodegenerative diseases.15,16 
According to research from Aschenco et al., 
lifestyle interventions including a healthy diet, 
regular exercise, weight control, and smoking 
cessation had been shown to increase HDL level 
which also had neuroprotective effects.16 In 
addition, HDL will be mediated by the activity of 
cholesterol ester transfer protein (CETP) which also 
associated with increased life expectancy, 
increased cognitive function, and dementia-free 
conditions.13,16 HDL can suppress Aβ production by 
lowering cellular cholesterol through activation of 
cholesterol reverse transport mediated by ABC 
transporter. HDL can also directly bind excess Aβ to 
inhibit its oligomerization. Oligomerization is a 
major step in the transformation of toxic 
monomeric peptides into neurotoxic compounds 
that can cause memory loss.17 
Meanwhile, research by Yin et al. showed that high 
triglyceride level was associated with risk of 
cognitive dysfunction.18 Recent molecular studies 
had shown that decreased triglyceride level could 
increase the transport of ghrelin and insulin across 
the blood-brain barrier, which could have a 
positive effect on cognitive function.19 However, 
increase in serum triglyceride level can trigger the 
emergence of orexigenic hypothalamic peptides 
which have negative effect on cognitive function. 
This mechanism makes triglyceride plays an 
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 Another research from Schilling et al. stated that 
the triglyceride level circulating during fasting were 
in the form of very low-density lipoprotein (VLDL) 
which was synthesized by the liver using saturated 
fatty acids.19 Therefore, higher triglyceride level 
indicates the amount of saturated fatty acids in 
abundance. Saturated fatty acids will increase the 
production of inflammatory cytokines. Studies had 
shown that high intake of saturated fatty acids 
could accelerate cognitive decline or increase the 
risk of dementia.18 
Cholesterol actually plays an important role in the 
maintenance of the lipid bilayer of cell membranes 
(lipid rafts). Changes in total cholesterol level can 
affect cell membrane function which may interfere 
with synaptic transmission in some 
neurotransmitter systems. Research by Chrichton 
et al. had shown an association between changes 
in serum cholesterol level and the 5-
hydroxytryptamine (5-HT) system.21 A 5-HT system 
deficit can manifest in some events of mood or 
appetite regulation disorders and has potential to 
affect cognitive function through impaired 
transmission of the frontal lobe. Based on the 
important role of lipid in cell maintenance, 
cholesterol plays an important role in brain 
development and function. Fatty acids that make 
up cholesterol are important molecular 
components that determine the integrity and 
performance of the brain, so maintained fatty acid 
level are essential for good brain function.20 In 
addition, unsaturated fatty acids can reduce the 
production of inflammatory cytokines or decrease 
tissue response. Research had shown that high 
intake of unsaturated fatty acids could protect 
cognitive function or reduce the risk of dementia.18 
Cholesterol is very important in myelination and 
formation of synapses and dendrites. Very low 
cholesterol level can also have an adverse effect on 
brain, especially during its development period.21,22 
In this study, the relationship between increased 
total cholesterol level and cognitive function was 
not statistically significant. This result is in line with 
the research of Elias et al. which stated that very 
low cholesterol level and impaired cognitive 
function was closely related to the need of total 
cholesterol for metabolic processes of nerve cells. 
The interaction between plasma cholesterol level, 
cholesterol contained in cell membranes, and very 
complex serotonergic activity may explain the 
negative effect of very low total cholesterol level 
on cognitive function.23 Although the cholesterol-
serotonin hypothesis had been developed to 
explain the relationship between very low total 
cholesterol level, violent behavior, and suicide, it is 
possible that the adverse modulation effects of low 
total cholesterol level on serotonergic activity may 
result in the role of serotonin in cognitive 
function.23 
Meanwhile, research by Oliveira et al. stated that 
high total cholesterol level which usually occurred 
in conjunction with chronic disease, metabolic 
syndrome, poor nutritional intake, and malignancy 
could ultimately be associated with poor cognitive 
function.24 These many other components and 
comorbid factors affecting the increase of total 
cholesterol level might also cause the result of 
analysis about relationship between total 
cholesterol level and cognitive function was 
statistically insignificant. 
In this study, it was also found that the relationship 
between increased LDL cholesterol level and 
cognitive function was not statistically significant. 
The pathophysiological mechanism of high LDL 
level in causing dementia in geriatric patients is still 
unclear, but the study of Anstey et al. mentioned 
that there was a possible relationship between the 
carotid artery atherosclerosis process and cognitive 
decline through cerebral embolism or 
hypoperfusion mediated by higher LDL level.25 In 
addition, Reitz et al. stated that lipid peroxidase 
which might be a major pro-inflammatory factor in 
the aging process and hypercholesterolemic 
conditions could cause microglia activation and 
beta Aβ plaque deposits.26 In contrast, study of Ma 
et al. found that restricting diet rich in LDL 
cholesterol could reduce the susceptibility of the 
brain to acute injury such as stroke and the 
possibility of age-related retardation of cognitive 
function.27 Thus, oxidation of LDL cholesterol in 
brain may be more relevant to the pathogenesis of 
dementia cases. vascular dementia, or dementia 
with mixed pathology (Alzheimer's disease co-
occurring with stroke). This argument is also 
supported by research from Ma et al. which stated 
that the relationship between LDL cholesterol level 
and decreased cognitive function was statistically 





 In this study, comorbid diseases such as stroke, 
hypertension, and diabetes mellitus which might 
be confounding factors and affect laboratory 
values were excluded. As research by Dimopoulos 
et al. stated that education level was inversely 
correlated with dementia risk and observed 
existing references from the Perhimpunan Dokter 
Spesialis Saraf Indonesia (PERDOSSI), researchers 
also attempted to exclude respondents who had 
history of formal education less than six years and 
could not communicate verbally using Indonesian, 
so the research data would be homogeneous.3,12 
This study was a cross-sectional analysis involving 
only one clinical evaluation and one individual lipid 
profile examination without further follow-up. 
Dynamic changes in cholesterol level over time 
could not be considered in this study, making it 
difficult for researchers to distinguish either 
changes in lipid profile preceded cognitive 
impairment or changes in lipid profile developed 
during the course of cognitive impairment. 
Another limitation of this study was the absence of 
confirmed apoE4 genotype data as risk factor for 
Alzheimer's dementia.10,16 
Finally, the findings of this study supported the 
potential benefit of measuring lipid profiles as 
biomarkers in the prevention of dementia in 
geriatrics and provided an indication for further 
research in the future. Apart from the need of 
dementia treatment options, there is actually an 
urgent need for the discovery of new biomarkers 
of early dementia as well as biomarkers for 
monitoring the severity of dementia which may 
also be useful as new dementia treatment targets. 
In addition, the condition of the geriatric patients 
involved in this study was quite healthy, as seen 
from the exclusion criteria that included 
degenerative diseases (such as acute coronary 
syndrome, hypertension, and diabetes mellitus), 
but the samples obtained were quite large. This 
finding was an interesting aspect and could be a 
topic for further research. 
 
Conclusion  
There was a significant relationship between HDL 
cholesterol level and triglyceride level with 
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